Socio-cultural determinants of anticipated acceptance of an oral cholera vaccine in Western Kenya

Epidemiology and Infection

Volumn 141, Issue 3, 2013, Pages 639-650

  Sundaram, N ^a,b   Schaetti, C ^a,b   Chaignat, C L ^c   Hutubessy, R ^c   Nyambedha, E O ^d   Mbonga, L A ^d   Weiss, M G ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d MASENO UNIVERSITY   (Kenya)

Author keywords

Cholera; Kenya; oral cholera vaccine; social and cultural determinants; vaccine acceptance

Indexed keywords

CHOLERA VACCINE;

ARTICLE; ATTITUDE TO HEALTH; CHOLERA; CLINICAL FEATURE; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DRUG COST; DRUG RESPONSE; EDUCATIONAL STATUS; HUMAN; INFECTION PREVENTION; KENYA; LOWEST INCOME GROUP; PERSONAL EXPERIENCE; RURAL AREA; SOCIAL ASPECT; URBAN AREA;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; CHOLERA; CHOLERA VACCINES; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INCOME; KENYA; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PLANT PREPARATIONS; RELIGION; RURAL POPULATION; THIRST; URBAN POPULATION; YOUNG ADULT;

EID: 84876895496     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812000829     Document Type: Article

References (40)

1. Lopez AD, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757.
2. Zuckerman JN, Rombo L, Fisch A. The true burden and risk of cholera: implications for prevention and control. Lancet Infectious Diseases 2007; 7: 521-530.
3. WHO. Cholera, 2009. Weekly Epidemiological Record 2010; 85: 293-308.
4. WHO. Cholera vaccines : WHO position paper. Weekly Epidemiological Record 2010; 85: 117-128.
5. WHO, UNICEF. Meeting the MDG water and sanitation target : The urban and rural challenge of the decade. Geneva: WHO, 2006.
6. Global Task Force on Cholera Control, WHO. Oral cholera vaccine use in complex emergencies: what next? Report of a WHO meeting, 14-16 December 2005, Cairo, Egypt. Geneva: World Health Organization, 2006; Report no. WHO/CDS/NTD/IDM/2006.2.
7. Lucas ME, et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. New England Journal of Medicine 2005; 352: 757-767.
8. Sur D, et al. Efficacy of a low-cost, inactivated wholecell oral cholera vaccine : results from 3 years of followup of a randomized, controlled trial. PLoS Neglected Tropical Diseases 2011; 5: e1289.
9. Larson HJ, et al. Addressing the vaccine confidence gap. Lancet 2011; 378: 526-535.
10. Stanton BF. Assessment of relevant cultural considerations is essential for the success of a vaccine. Journal of Health, Population and Nutrition 2004; 22: 286-292.
11. Raude J, Caille-Brillet AL, Setbon M. The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why? PLoS Currents 2010; 2: RRN1188.
12. Mortensen GL. Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study. BMC Public Health 2010; 10: 68.
13. Islam Z, et al. Private demand for cholera vaccines in rural Matlab, Bangladesh. Health Policy 2008; 85: 184-195.
14. Kim D, et al. Private demand for cholera vaccines in Hue, Vietnam. Value in Health 2008; 11: 119-128.
15. Lucas ME, et al. Private demand for cholera vaccines in Beira, Mozambique. Vaccine 2007; 25: 2599-2609.
16. DeRoeck D, et al. Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine 2005; 23: 2762-2774.
17. Ali M, et al. Community participation in two vaccination trials in slums of Kolkata, India: a multi-level analysis. Journal of Health, Population and Nutrition 2010; 28: 450-457.
18. Feikin DR, Tabu CW, Gichuki J. Does water hyacinth on East African lakes promote cholera outbreaks? American Journal of Tropical Medicine and Hygiene 2010; 83: 370-373.
19. Shapiro RL, et al. Transmission of epidemic Vibrio cholerae O1 in rural western Kenya associated with drinking water from Lake Victoria : an environmental reservoir for cholera? American Journal of Tropical Medicine and Hygiene 1999; 60: 271-276.
20. Shikanga OT, et al. High mortality in a cholera outbreak in western Kenya after post-election violence in 2008. American Journal of Tropical Medicine and Hygiene 2009; 81: 1085-1090.
21. Weiss MG. Cultural epidemiology: an introduction and overview. Anthropology and Medicine 2001; 8: 5-29.
22. UN-HABITAT. Cities without slums: situational analysis of informal settlements in Kisumu. Nairobi: United Nations Human Settlements Programme (UNHABITAT), 2005; Report no. HS/783/05E.
23. Olago D, et al. Climatic, socio-economic, and health factors affecting human vulnerability to cholera in the Lake Victoria basin, East Africa. Ambio 2007; 36: 350-358.
24. Ministry of public health and sanitation. Siaya district health profile. Siaya, Kenya: Health Records Office, 2009.
25. Schaetti C, et al. Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance. BMC Public Health 2009; 9: 99.
26. Weiss MG. Explanatory Model Interview Catalogue (EMIC): framework for comparative study of illness. Transcultural Psychiatry 1997; 34: 235-263.
27. Schaetti C, et al. Social and cultural features of cholera and shigellosis in peri-urban and rural communities of Zanzibar. BMC Infectious Diseases 2010; 10: 339.
28. Teitler-Regev S, Shahrabani S, Benzion U. Factors affecting intention among students to be vaccinated against A/H1N1 influenza: a health belief model approach. Advances in Preventive Medicine 2011; 2011: 353207.
29. Nations MK, Monte CM. 'I'm not dog, no! ' : cries of resistance against cholera control campaigns. Social Science & Medicine 1996; 43: 1007-1024.
30. Parker M, Allen T, Hastings J. Resisting control of neglected tropical diseases : dilemmas in the mass treatment of schistosomiasis and soil-transmitted helminths in north-west Uganda. Journal of Biosocial Science 2008; 40: 161-181.
31. Kaljee LM, et al. Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme. Journal of Health, Population and Nutrition 2004; 22: 293-303.
32. Mitchell S, et al. Equity and vaccine uptake: a crosssectional study of measles vaccination in Lasbela District, Pakistan. BMC International Health and Human Rights 2009; 9 (Suppl.1) : S7.
33. Matu EN, vanStaden J. Antibacterial and anti-inflammatory activities of some plants used for medicinal purposes in Kenya. Journal of Ethnopharmacology 2003; 87: 35-41.
34. Cassell JA, et al. The social shaping of childhood vaccination practice in rural and urban Gambia. Health Policy and Planning 2006; 21: 373-391.
35. Ruijs WL, et al. Religious subgroups influencing vaccination coverage in the Dutch Bible belt : an ecological study. BMC Public Health 2011; 11: 102.
36. Jegede AS. What led to the Nigerian boycott of the polio vaccination campaign? PLoS Medicine 2007; 4: e73.
37. Fourn L, et al. Determinants of parents' reticence toward vaccination in urban areas in Benin (West Africa). BMC International Health and Human Rights 2009; 9 (Suppl.1) : S14.
38. Prince R. The Legio Maria church in Western Kenya: healing with the Holy Spirit and the rejection of medicines (dissertation). London, UK: University College London, 1999, 72 pp.
39. Ad-hoc Cholera Vaccine Working Group, WHO. Background paper on the integration of oral cholera vaccines into global cholera control programmes presented to the WHO SAGE. (http://www.who.int/immunization/sage/1-Background- Paper-Cholera-Vaccines-FINALdraft-13-oct-v2.pdf), 2009. Accessed 1 February 2012.
40. Mpazi VM, Mnyika KS. Knowledge, attitudes and practices regarding cholera outbreaks in Ilala municipality of Dar es Salaam region, Tanzania. East African Journal of Public Health 2005; 2: 6-11.